Baxter’s Colleague Consent Decree Enjoins Sales, Expands Obligations

Baxter signed a consent decree with FDA June 29 forbidding the sale of its widely used but malfunction-prone Colleague intravenous infusion pump until the firm complies with manufacturing quality regulations

More from Archive

More from Medtech Insight